Narrowed 2025 Ongoing Operations Adjusted EBITDA 1 guidance range to $5.7 billion to $5.9 billion and raised the midpoint and narrowed the guidance range for Ongoing Operations Adjusted FCFbG 1 to ...
Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the three months ...
Globally significant Mineral Resource with extensive mine life and first quartile cash costs driving significant Free Cash Flow generation: Average annual copper equivalent production of over 300,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback